Cargando…

Aspartate β-hydroxylase as a target for cancer therapy

As metastasis is a major cause of death in cancer patients, new anti-metastatic strategies are needed to improve cancer therapy outcomes. Numerous pathways have been shown to contribute to migration and invasion of malignant tumors. Aspartate β-hydroxylase (ASPH) is a key player in the malignant tra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanwal, Madiha, Smahel, Michal, Olsen, Mark, Smahelova, Jana, Tachezy, Ruth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433162/ https://www.ncbi.nlm.nih.gov/pubmed/32811566 http://dx.doi.org/10.1186/s13046-020-01669-w

Ejemplares similares

Experimental Combined Immunotherapy of Tumours with Major Histocompatibility Complex Class I Downregulation
por: Grzelak, Adrianna, et al.
Publicado: (2018)

Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer
por: Benelli, Roberto, et al.
Publicado: (2020)

Diverse molecular functions of aspartate β-hydroxylase in cancer
por: Zheng, Wenqian, et al.
Publicado: (2020)

ARG1 mRNA Level Is a Promising Prognostic Marker in Head and Neck Squamous Cell Carcinomas
por: Pokrývková, Barbora, et al.
Publicado: (2021)

Aspartate-β-hydroxylase (ASPH): A potential therapeutic target in human malignant gliomas
por: Sturla, Lisa-Marie, et al.
Publicado: (2016)

Human Papillomavirus Type-Specific Prevalence in the Cervical Cancer Screening Population of Czech Women
por: Tachezy, Ruth, et al.
Publicado: (2013)

Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype
por: Dong, Xiaoqun, et al.
Publicado: (2014)

Correction: Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype
por: Dong, Xiaoqun, et al.
Publicado: (2019)

Erratum: Benelli, R., et al. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 2020, 12, 971
por: Benelli, Roberto, et al.
Publicado: (2020)

Distinct Responsiveness of Tumor-Associated Macrophages to Immunotherapy of Tumors with Different Mechanisms of Major Histocompatibility Complex Class I Downregulation
por: Piatakova, Adrianna, et al.
Publicado: (2021)

Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer
por: Gan, Xuejun, et al.
Publicado: (2023)

Characterization of the Relationship Between the Expression of Aspartate β-Hydroxylase and the Pathological Characteristics of Breast Cancer
por: Zhang, Yanan, et al.
Publicado: (2020)

Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target
por: Holtzman, Noa G., et al.
Publicado: (2021)

Aspartate β-hydroxylase disrupts mitochondrial DNA stability and function in hepatocellular carcinoma
por: Tang, C, et al.
Publicado: (2017)

Detailed Characteristics of Tonsillar Tumors with Extrachromosomal or Integrated Form of Human Papillomavirus
por: Pokrývková, Barbora, et al.
Publicado: (2019)

Endocrine sensitivity of estrogen receptor‐positive breast cancer is negatively correlated with aspartate‐β‐hydroxylase expression
por: Shimoda, Masafumi, et al.
Publicado: (2017)

Synthesis of Novel Pyridine‐Carboxylates as Small‐Molecule Inhibitors of Human Aspartate/Asparagine‐β‐Hydroxylase
por: Brewitz, Lennart, et al.
Publicado: (2020)

Synthesis of 2-oxoglutarate derivatives and their evaluation as cosubstrates and inhibitors of human aspartate/asparagine-β-hydroxylase
por: Brewitz, Lennart, et al.
Publicado: (2020)

Novel Approach to Overcome Defects of Cell-SELEX in Developing Aptamers against Aspartate β-Hydroxylase
por: Bakhtiari, Hadi, et al.
Publicado: (2021)

Small-molecule active pharmaceutical ingredients of approved cancer therapeutics inhibit human aspartate/asparagine-β-hydroxylase
por: Brewitz, Lennart, et al.
Publicado: (2020)

PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression
por: Šmahel, Michal
Publicado: (2017)

Implementation of Mass Cytometry for Immunoprofiling of Patients with Solid Tumors
por: Poláková, Ingrid, et al.
Publicado: (2019)

Construction and Characterization of Adenovirus Vectors Encoding Aspartate-β-Hydroxylase to Preliminary Application in Immunotherapy of Hepatocellular Carcinoma
por: Zhou, Yujiao, et al.
Publicado: (2018)

Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway
por: Ogawa, Kosuke, et al.
Publicado: (2019)

Human Papillomavirus Genotype Distribution in Czech Women and Men with Diseases Etiologically Linked to HPV
por: Tachezy, Ruth, et al.
Publicado: (2011)

Kinetic parameters of human aspartate/asparagine–β-hydroxylase suggest that it has a possible function in oxygen sensing
por: Brewitz, Lennart, et al.
Publicado: (2020)

Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors
por: Brewitz, Lennart, et al.
Publicado: (2020)

Lack of Conserved miRNA Deregulation in HPV-Induced Squamous Cell Carcinomas
por: Nunvar, Jaroslav, et al.
Publicado: (2021)

Author Correction: Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors
por: Brewitz, Lennart, et al.
Publicado: (2020)

Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones
por: Vojtechova, Zuzana, et al.
Publicado: (2016)

Aspartate/asparagine-β-hydroxylase crystal structures reveal an unexpected epidermal growth factor-like domain substrate disulfide pattern
por: Pfeffer, Inga, et al.
Publicado: (2019)

Feasibility of Real-time Behavior Monitoring Via Mobile Technology in Czech Adults Aged 50 Years and Above: 12-Week Study With Ecological Momentary Assessment
por: Elavsky, Steriani, et al.
Publicado: (2021)

Decreased expression of prolyl hydroxylase 1 is associated with poor prognosis in colorectal cancers
por: Melling, Nathaniel, et al.
Publicado: (2023)

HIF-Prolyl Hydroxylase Domain Proteins (PHDs) in Cancer—Potential Targets for Anti-Tumor Therapy?
por: Gaete, Diana, et al.
Publicado: (2021)

Targeting aspartate aminotransferase in breast cancer
por: Thornburg, Joshua Marshall, et al.
Publicado: (2008)

Prolyl 4 Hydroxylase: A Critical Target in the Pathophysiology of Diseases
por: Kant, Ravi, et al.
Publicado: (2013)

Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma
por: Sun, Shiquan, et al.
Publicado: (2023)

Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression
por: Huang, Chiung-Kuei, et al.
Publicado: (2016)

Genetic diversity of tyrosine hydroxylase (TH) and dopamine β-hydroxylase (DBH) genes in cattle breeds
por: Lourenco-Jaramillo, Diana Lelidett, et al.
Publicado: (2012)

A biosynthetic aspartate N-hydroxylase performs successive oxidations by holding intermediates at a site away from the catalytic center
por: Rotilio, Laura, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5mq9epmqtnj47irkhql9n08ivt